DOUBLE-BLIND

a type of clinical trial in which neither the subject nor the investigator knows what treatment, if any, the subject is receiving. At the end of the trial the "code" is broken and data are analyzed. Double-blinding is done to minimize bias due to the expectations of the subject, investigator(s) and/or healthcare provider(s).